Stocks and Investing
Stocks and Investing
Thu, February 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steven Seedhouse Maintained (VKTX) at Buy with Increased Target to $12 on, Feb 9th, 2023
Steven Seedhouse of Raymond James, Maintained "Viking Therapeutics, Inc." (VKTX) at Buy with Increased Target from $11 to $12 on, Feb 9th, 2023.
Steven has made no other calls on VKTX in the last 4 months.
There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Steven's Rating of Hold.
This is the rating of the analyst that currently disagrees with Steven
- Naz Rahman of "Maxim Group" Maintained at Strong Buy with Increased Target to $15 on, Tuesday, December 20th, 2022
Contributing Sources